Your browser doesn't support javascript.
loading
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data.
Sandecká, Viera; Pour, Ludek; Spicka, Ivan; Minarík, Jirí; Radocha, Jakub; Jelínek, Tomás; Heindorfer, Adriana; Pavlícek, Petr; Sýkora, Michal; Jungová, Alexandra; Kessler, Petr; Wróbel, Marek; Starostka, David; Ullrychová, Jana; Stejskal, Lukás; Stork, Martin; Straub, Jan; Pika, Tomás; Brozová, Lucie; Sevcíková, Sabina; Maisnar, Vladimír; Hájek, Roman.
Afiliación
  • Sandecká V; Department of Internal Medicine, Hematology and Oncology, University Hospital, Brno, Czech Republic.
  • Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital, Brno, Czech Republic.
  • Spicka I; 1st Department of Medicine, Department of Hematology, Charles University and General Hospital, Prague, Czech Republic.
  • Minarík J; Department of Hemato-Oncology, University Hospital Olomouc, Olomouc, Czech Republic.
  • Radocha J; 4th Department of Internal Medicine, Hematology, University Hospital and Charles University in Hradec Kralove, Hradec Kralove, Czech Republic.
  • Jelínek T; Department of Hematooncology, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic.
  • Heindorfer A; Department of Clinical Hematology, Hospital Liberec, Czech Republic.
  • Pavlícek P; Department of Internal Medicine and Hematology, Charles University and Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Sýkora M; Department of Clinical Hematology, Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic.
  • Jungová A; Hematology and Oncology Department, Charles University Hospital Pilsen, Pilsen, Czech Republic.
  • Kessler P; Department of Hematology and Transfusion Medicine, Hospital Pelhrimov, Czech Republic.
  • Wróbel M; Department of Clinical Hematology, Hospital Novy Jicin, Czech Republic.
  • Starostka D; Department of Clinical Hematology, Hospital Havirov, Czech Republic.
  • Ullrychová J; Department of Clinical Hematology, Regional Health Corporation, Masaryk Hospital, Usti nad Labem, Czech Republic.
  • Stejskal L; Department of Hematology, Silesian Hospital in Opava, Opava, Czech Republic.
  • Stork M; Department of Internal Medicine, Hematology and Oncology, University Hospital, Brno, Czech Republic.
  • Straub J; 1st Department of Medicine, Department of Hematology, Charles University and General Hospital, Prague, Czech Republic.
  • Pika T; Department of Hemato-Oncology, University Hospital Olomouc, Olomouc, Czech Republic.
  • Brozová L; Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
  • Sevcíková S; Babak Myeloma Group, Department of Pathophysiology, Masaryk University, Brno, Czech Republic.
  • Maisnar V; 4th Department of Internal Medicine, Hematology, University Hospital and Charles University in Hradec Kralove, Hradec Kralove, Czech Republic.
  • Hájek R; Department of Hematooncology, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic.
Eur J Haematol ; 107(4): 466-474, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34272773

Texto completo: 1 Colección: 01-internacional Asunto principal: Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Sistema de Registros / Bortezomib / Melfalán / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: República Checa

Texto completo: 1 Colección: 01-internacional Asunto principal: Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Sistema de Registros / Bortezomib / Melfalán / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: República Checa